Factors predicting survival in patients with locally advanced pancreatic cancer undergoing pancreatectomy with arterial resection

被引:15
|
作者
Napoli, Niccolo [5 ]
Kauffmann, Emanuele [5 ]
Cacace, Concetta [5 ]
Menonna, Francesca [5 ]
Caramella, Davide [1 ]
Cappelli, Carla [1 ]
Campani, Daniela [2 ]
Cacciato Insilla, Andrea [2 ]
Vasile, Enrico [3 ]
Vivaldi, Caterina [3 ]
Fornaro, Lorenzo [3 ]
Amorese, Gabriella [4 ]
Vistoli, Fabio [5 ]
Boggi, Ugo [5 ]
机构
[1] Univ Pisa, Azienda Osped Univ Pisana, Div Radiol, Pisa, Italy
[2] Univ Pisa, Azienda Osped Univ Pisana, Div Pathol, Pisa, Italy
[3] Univ Pisa, Azienda Osped Univ Pisana, Div Oncol, Pisa, Italy
[4] Univ Pisa, Azienda Osped Univ Pisana, Div Anesthesia & Intens Care, Pisa, Italy
[5] Univ Pisa, Azienda Osped Univ Pisana, Div Gen & Transplant Surg, Pisa, Italy
关键词
Locally advanced pancreatic cancer; Pancreatic cancer; Pancreatectomy; Arterial resection; Vascular resection; Prognostic score; INTERNATIONAL STUDY-GROUP; TO-LYMPHOCYTE RATIO; CLINICAL-USEFULNESS; R1; RESECTION; SURGERY; CA125; COMPLICATIONS; CHEMOTHERAPY; METAANALYSIS; METASTASIS;
D O I
10.1007/s13304-020-00883-7
中图分类号
R61 [外科手术学];
学科分类号
摘要
Pancreatectomy with arterial resection is a treatment option in selected patients with locally advanced pancreatic cancer. This study aimed to identify factors predicting cancer-specific survival in this patient population. A single-Institution prospective database was used. Pre-operative prognostic factors were identified and used to develop a prognostic score. Matching with pathologic parameters was used for internal validation. In a patient population with a median Ca 19.9 level of 19.8 U/mL(IQR: 7.1-77), cancer-specific survival was predicted by: metabolic deterioration of diabetes (OR = 0.22,p = 0.0012), platelet count (OR = 1.00;p = 0.0013), serum level of Ca 15.3 (OR = 1.01,p = 0.0018) and Ca 125 (OR = 1.02,p = 0.00000137), neutrophils-to-lymphocytes ratio (OR = 1.16;p = 0.00015), lymphocytes-to-monocytes ratio (OR = 0.88;p = 0.00233), platelets-to-lymphocytes ratio (OR = 0.99;p = 0.00118), and FOLFIRINOX neoadjuvant chemotherapy (OR = 0.57;p = 0.00144). A prognostic score was developed and three risk groups were identified. Harrell's C-Index was 0.74. Median cancer-specific survival was 16.0 months (IQR: 12.3-28.2) for the high-risk group, 24.7 months (IQR: 17.6-33.4) for the intermediate-risk group, and 39.0 months (IQR: 22.7-NA) for the low-risk group (p = 0.0003). Matching the three risk groups against pathology parameters, N2 rate was 61.9, 42.1, and 23.8% (p = 0.04), median value of lymph-node ratio was 0.07 (IQR: 0.05-0.14), 0.04 (IQR:0.02-0.07), and 0.03 (IQR: 0.01-0.04) (p = 0.008), and mean value of logarithm odds of positive nodes was - 1.07 +/- 0.5, - 1.3 +/- 0.4, and - 1.4 +/- 0.4 (p = 0.03), in the high-risk, intermediate-risk, and low-risk groups, respectively. An online calculator is available at. The prognostic factors identified in this study predict cancer-specific survival in patients with locally advanced pancreatic cancer and low Ca 19.9 levels undergoing pancreatectomy with arterial resection.
引用
收藏
页码:233 / 249
页数:17
相关论文
共 50 条
  • [21] Factors Predicting the Appearance of Neutropenia in Patients with Advanced Pancreatic Cancer Undergoing Gemcitabine Therapy
    Yoneyama, Keiichiro
    Katsumoto, Emi
    Kurihara, Tatsuya
    Kogo, Mari
    Ikegami, Akitoshi
    Imawari, Michiro
    Shimada, Ken
    Yoshikumi, Hiroki
    Inoue, Kazuaki
    Kiuchi, Yuji
    HEPATO-GASTROENTEROLOGY, 2012, 59 (115) : 894 - 898
  • [22] Vascular Resection in Pancreatectomy-Is It Safe and Useful for Patients with Advanced Pancreatic Cancer?
    Jablonska, Beata
    Krol, Robert
    Mrowiec, Slawomir
    CANCERS, 2022, 14 (05)
  • [23] Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection
    Gemenetzis, Georgios
    Groot, Vincent P.
    Blair, Alex B.
    Laheru, Daniel A.
    Zheng, Lei
    Narang, Amol K.
    Fishman, Elliot K.
    Hruban, Ralph H.
    Yu, Jun
    Burkhart, Richard A.
    Cameron, John L.
    Weiss, Matthew J.
    Wolfgang, Christopher L.
    He, Jin
    ANNALS OF SURGERY, 2019, 270 (02) : 340 - 347
  • [24] Pancreatectomy With Arterial Resection and Reconstruction for Locally Advanced Pancreatic Cancer Involving Major Visceral Arteries (T4 lesions) Can Acheive R0 Resection With Improved Survival
    Genyk, Yuri
    Barzi, Afsaneh
    DiNorcia, Joseph
    Sahakian, Ara
    Iqbal, Syma
    Buxbaum, James L.
    El-Khoueiry, Anthony
    Van Dam, Jacques
    Lenz, Heinz-Josef
    Selby, Robert R.
    GASTROENTEROLOGY, 2016, 150 (04) : S1253 - S1254
  • [25] Predictors of undergoing multivisceral resection, margin status and survival in Dutch patients with locally advanced colorectal cancer
    de Nes, L. C. F.
    van der Heijden, J. A. G.
    Verstegen, M. G.
    Drager, L.
    Tanis, P. J.
    Verhoeven, R. H. A.
    de Wilt, J. H. W.
    EJSO, 2022, 48 (05): : 1144 - 1152
  • [26] Improved survival and quality of life in patients undergoing R1 pancreatic resection compared to patients with locally advanced unresectable pancreatic adenocarcinoma
    Nordby, Tom
    Ikdahl, Tone
    Lothe, Inger Marie Bowitz
    Fagerland, Morten W.
    Heiberg, Turid
    Hauge, Truls
    Labori, Knut Joergen
    Buanes, Trond
    PANCREATOLOGY, 2013, 13 (02) : 180 - 185
  • [27] Extended Pancreatectomy with En Bloc Resection of the Celiac Axis for Locally Advanced Cancer of Pancreatic Body and Tail
    Chen, Bo
    Hu, Sanyuan
    Wang, Lei
    Wachtel, Mitchell S.
    Frezza, Eldo E.
    HEPATO-GASTROENTEROLOGY, 2008, 55 (88) : 2252 - 2255
  • [28] Systematic review of outcomes after distal pancreatectomy with coeliac axis resection for locally advanced pancreatic cancer
    Klompmaker, S.
    de Rooij, T.
    Korteweg, J. J.
    van Dieren, S.
    van Lienden, K. P.
    van Gulik, T. M.
    Busch, O. R.
    Besselink, M. G.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (08) : 941 - 949
  • [29] ASO Author Reflections: Radical Resection for Locally Advanced Pancreatic Cancer: Arterial Resection Versus Divestment?
    Kumar, Naveena A. N.
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (07) : 4704 - 4705
  • [30] Outcomes after extended pancreatectomy in patients with borderline resectable and locally advanced pancreatic cancer
    Hartwig, W.
    Gluth, A.
    Hinz, U.
    Koliogiannis, D.
    Strobel, O.
    Hackert, T.
    Werner, J.
    Buechler, M. W.
    BRITISH JOURNAL OF SURGERY, 2016, 103 (12) : 1683 - 1694